219 related articles for article (PubMed ID: 11096437)
21. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
Van den Bosch L
Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice.
Bordet T; Lesbordes JC; Rouhani S; Castelnau-Ptakhine L; Schmalbruch H; Haase G; Kahn A
Hum Mol Genet; 2001 Sep; 10(18):1925-33. PubMed ID: 11555629
[TBL] [Abstract][Full Text] [Related]
23. Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis.
McEachin ZT; Donsante A; Boulis N
Methods Mol Biol; 2016; 1382():399-408. PubMed ID: 26611602
[TBL] [Abstract][Full Text] [Related]
24. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
[TBL] [Abstract][Full Text] [Related]
25. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
[TBL] [Abstract][Full Text] [Related]
26. Gene Therapy for ALS-A Perspective.
Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113
[TBL] [Abstract][Full Text] [Related]
27. Synaptotagmin 13 is neuroprotective across motor neuron diseases.
Nizzardo M; Taiana M; Rizzo F; Aguila Benitez J; Nijssen J; Allodi I; Melzi V; Bresolin N; Comi GP; Hedlund E; Corti S
Acta Neuropathol; 2020 May; 139(5):837-853. PubMed ID: 32065260
[TBL] [Abstract][Full Text] [Related]
28. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease.
Ince P; Stout N; Shaw P; Slade J; Hunziker W; Heizmann CW; Baimbridge KG
Neuropathol Appl Neurobiol; 1993 Aug; 19(4):291-9. PubMed ID: 8232749
[TBL] [Abstract][Full Text] [Related]
29. Healthy and diseased corticospinal motor neurons are selectively transduced upon direct AAV2-2 injection into the motor cortex.
Jara JH; Stanford MJ; Zhu Y; Tu M; Hauswirth WW; Bohn MC; DeVries SH; Özdinler PH
Gene Ther; 2016 Mar; 23(3):272-82. PubMed ID: 26704722
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic horizons for amyotrophic lateral sclerosis.
Rothstein JD
Curr Opin Neurobiol; 1996 Oct; 6(5):679-87. PubMed ID: 8937834
[TBL] [Abstract][Full Text] [Related]
31. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis.
Kaspar BK; Frost LM; Christian L; Umapathi P; Gage FH
Ann Neurol; 2005 May; 57(5):649-55. PubMed ID: 15852403
[TBL] [Abstract][Full Text] [Related]
32. Cellular therapies in motor neuron diseases.
Nayak MS; Kim YS; Goldman M; Keirstead HS; Kerr DA
Biochim Biophys Acta; 2006; 1762(11-12):1128-38. PubMed ID: 16872810
[TBL] [Abstract][Full Text] [Related]
33. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
34. Gene therapy for ALS delivers.
Boillée S; Cleveland DW
Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
[TBL] [Abstract][Full Text] [Related]
35. The genetic and molecular mechanisms of motor neuron disease.
Wong PC; Rothstein JD; Price DL
Curr Opin Neurobiol; 1998 Dec; 8(6):791-9. PubMed ID: 9914243
[TBL] [Abstract][Full Text] [Related]
36. Mice, the motor system, and human motor neuron pathology.
Nicholson SJ; Witherden AS; Hafezparast M; Martin JE; Fisher EM
Mamm Genome; 2000 Dec; 11(12):1041-52. PubMed ID: 11130970
[TBL] [Abstract][Full Text] [Related]
37. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases.
Azzouz M; Mazarakis N
Curr Gene Ther; 2004 Sep; 4(3):277-86. PubMed ID: 15384941
[TBL] [Abstract][Full Text] [Related]
38. [Gene Therapies in Motor Neuron Diseases ALS and SMA].
Günther R
Fortschr Neurol Psychiatr; 2023 Apr; 91(4):153-163. PubMed ID: 36822211
[TBL] [Abstract][Full Text] [Related]
39. Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy.
Naganska E; Matyja E
Folia Neuropathol; 2011; 49(1):1-13. PubMed ID: 21455838
[TBL] [Abstract][Full Text] [Related]
40. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
